Forelimb dyskinesia mediated by high-frequency stimulation of the subthalamic nucleus is linked to rapid activation of the NR2B subunit of N-methyl-d-aspartate receptors

European Journal of Neuroscience

Volumn 32, Issue 3, 2010, Pages 423-434

  Quintana, Adrien ^a,b   Melon, Christophe ^c   Goff, Lydia Kerkerian Le ^c   Salin, Pascal ^c   Savasta, Marc ^a,b,d   Sgambato Faure, Véronique ^a,b,e  

^a INSERM   (France)

^b UNIV GRENOBLE ALPES   (France)

^c AIX MARSEILLE UNIVERSITÉ   (France)

^d GRENOBLE UNIVERSITY HOSPITAL   (France)

^e UNIVERSITÉ LYON 1   (France)

Author keywords

106; CP 101; glutamate; high frequency stimulation; rat; subthalamic nucleus

Indexed keywords

DIZOCILPINE; LEVODOPA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; RECEPTOR SUBUNIT; TRAXOPRODIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DEPTH STIMULATION; CONTROLLED STUDY; DYSKINESIA; ENTOPEDUNCULAR NUCLEUS; FORELIMB; IMMUNOHISTOCHEMISTRY; LOCOMOTION; MALE; MOTOR CORTEX; MOTOR PERFORMANCE; NEUROTRANSMISSION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SUBTHALAMIC NUCLEUS;

EID: 77955133170     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2010.07290.x     Document Type: Article

References (88)

1. Andersson, M., Hilbertson, A. Cenci, M.A. (1999) Striatal fosB expression is causally linked with l-DOPA-induced abnormal involuntary movements and the associated upregulation of striatal prodynorphin mRNA in a rat model of Parkinson's disease. Neurobiol. Dis., 6, 461 474.
2. Aziz, T.Z., Peggs, D., Sambrook, M.A. Crossman, A.R. (1991) Lesion of the subthalamic nucleus for the alleviation of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP)-induced parkinsonism in the primate. Mov. Disord., 6, 288 292.
3. Bacci, J.J., Absi el, H., Manrique, C., Baunez, C., Salin, P. Kerkerian-Le Goff, L. (2004) Differential effects of prolonged high frequency stimulation and of excitotoxic lesion of the subthalamic nucleus on dopamine denervation-induced cellular defects in the rat striatum and globus pallidus. Eur. J. Neurosci., 20, 3331 3341.
4. Benabid, A.L., Benazzouz, A. Pollak, P. (2002) Mechanisms of deep brain stimulation. Mov. Disord., 17 (Suppl 3 S73 S74.
5. Benabid, A.L., Deuschl, G., Lang, A.E., Lyons, K.E. Rezai, A.R. (2006) Deep brain stimulation for Parkinson's disease. Mov. Disord., 21 (Suppl 14 S168 S170.
6. Benazzouz, A., Gross, C., Feger, J., Boraud, T. Bioulac, B. (1993) Reversal of rigidity and improvement in motor performance by subthalamic high-frequency stimulation in MPTP-treated monkeys. Eur. J. Neurosci., 5, 382 389.
7. Benazzouz, A., Piallat, B., Pollak, P. Benabid, A.L. (1995) Responses of substantia nigra pars reticulata and globus pallidus complex to high frequency stimulation of the subthalamic nucleus in rats: electrophysiological data. Neurosci. Lett., 189, 77 80.
8. Bergman, H., Wichmann, T. DeLong, M.R. (1990) Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science, 249, 1436 1438.
9. Bibbiani, F., Oh, J.D., Kielaite, A., Collins, M.A., Smith, C. Chase, T.N. (2005) Combined blockade of AMPA and NMDA glutamate receptors reduces levodopa-induced motor complications in animal models of PD. Exp. Neurol., 196, 422 429.
10. Blanchet, P.J., Konitsiotis, S., Whittemore, E.R., Zhou, Z.L., Woodward, R.M. Chase, T.N. (1999) Differing effects of N-methyl-D-aspartate receptor subtype selective antagonists on dyskinesias in levodopa-treated 1-methyl-4-phenyl-tetrahydropyridine monkeys. J. Pharmacol. Exp. Ther., 290, 1034 1040.
11. Blanchet, P.J., Calon, F., Morissette, M., Hadj Tahar, A., Belanger, N., Samadi, P., Grondin, R., Gregoire, L., Meltzer, L., Di Paolo, T. Bedard, P.J. (2004) Relevance of the MPTP primate model in the study of dyskinesia priming mechanisms. Parkinsonism Relat. Disord., 10, 297 304.
12. Boraud, T., Bezard, E., Bioulac, B. Gross, C. (1996) High frequency stimulation of the internal Globus Pallidus (GPi) simultaneously improves parkinsonian symptoms and reduces the firing frequency of GPi neurons in the MPTP-treated monkey. Neurosci. Lett., 215, 17 20.
13. Boulanger, L.M., Lombroso, P.J., Raghunathan, A., During, M.J., Wahle, P. Naegele, J.R. (1995) Cellular and molecular characterization of a brain-enriched protein tyrosine phosphatase. J. Neurosci., 15, 1532 1544.
14. Boulet, S., Lacombe, E., Carcenac, C., Feuerstein, C., Sgambato-Faure, V., Poupard, A. Savasta, M. (2006) Subthalamic stimulation-induced forelimb dyskinesias are linked to an increase in glutamate levels in the substantia nigra pars reticulata. J. Neurosci., 26, 10768 10776.
15. Braithwaite, S.P., Paul, S., Nairn, A.C. Lombroso, P.J. (2006) Synaptic plasticity: one STEP at a time. Trends Neurosci., 29, 452 458.
16. Caldeira, M.V., Melo, C.V., Pereira, D.B., Carvalho, R.F., Carvalho, A.L. Duarte, C.B. (2007) BDNF regulates the expression and traffic of NMDA receptors in cultured hippocampal neurons. Mol. Cell. Neurosci., 35, 208 219.
17. Calon, F., Morissette, M., Ghribi, O., Goulet, M., Grondin, R., Blanchet, P.J., Bedard, P.J. Di Paolo, T. (2002) Alteration of glutamate receptors in the striatum of dyskinetic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys following dopamine agonist treatment. Prog. Neuropsychopharmacol. Biol. Psychiatry, 26, 127 138.
18. Calon, F., Rajput, A.H., Hornykiewicz, O., Bedard, P.J. Di Paolo, T. (2003) Levodopa-induced motor complications are associated with alterations of glutamate receptors in Parkinson's disease. Neurobiol. Dis., 14, 404 416.
19. Cenci, M.A. Lindgren, H.S. (2007) Advances in understanding L-DOPA-induced dyskinesia. Curr. Opin. Neurobiol., 17, 665 671.
20. Cenci, M.A., Lee, C.S. Bjorklund, A. (1998) L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA. Eur. J. Neurosci., 10, 2694 2706.
21. Chase, T.N. Oh, J.D. (2000) Striatal dopamine- and glutamate-mediated dysregulation in experimental parkinsonism. Trends Neurosci., 23, S86 S91.
22. Chatha, B.T., Bernard, V., Streit, P. Bolam, J.P. (2000) Synaptic localization of ionotropic glutamate receptors in the rat substantia nigra. Neuroscience, 101, 1037 1051.
23. Chazot, P.L., Lawrence, S. Thompson, C.L. (2002) Studies on the subtype selectivity of CP-101,606: evidence for two classes of NR2B-selective NMDA receptor antagonists. Neuropharmacology, 42, 319 324.
24. Chen, B.S. Roche, K.W. (2007) Regulation of NMDA receptors by phosphorylation. Neuropharmacology, 53, 362 368.
25. Chenard, B.L., Bordner, J., Butler, T.W., Chambers, L.K., Collins, M.A., De Costa, D.L., Ducat, M.F., Dumont, M.L., Fox, C.B., Mena, E.E., Menniti, F.S., Nielsen, J., Pagnozzi, M.J., Richter, K.E.G., Ronau, R.T., Shalaby, I.A., Stemple, J.Z. White, W.F. (1995) (1S,2S)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4- phenylpiperidino)-1-propanol: a potent new neuroprotectant which blocks N-methyl-D-aspartate responses. J. Med. Chem., 38, 3138 3145.
26. Clarke, N.P. Bolam, J.P. (1998) Distribution of glutamate receptor subunits at neurochemically characterized synapses in the entopeduncular nucleus and subthalamic nucleus of the rat. J. Comp. Neurol., 397, 403 420.
27. Crossman, A.R., Sambrook, M.A. Jackson, A. (1984) Experimental hemichorea/hemiballismus in the monkey. Studies on the intracerebral site of action in a drug-induced dyskinesia. Brain, 107 (Pt 2 579 596.
28. Degos, B., Deniau, J.M., Le Cam, J., Mailly, P. Maurice, N. (2008) Evidence for a direct subthalamo-cortical loop circuit in the rat. Eur. J. Neurosci., 27, 2599 2610.
29. Dekundy, A., Pietraszek, M., Schaefer, D., Cenci, M.A. Danysz, W. (2006) Effects of group I metabotropic glutamate receptors blockade in experimental models of Parkinson's disease. Brain Res. Bull., 69, 318 326.
30. Dunah, A.W., Wang, Y., Yasuda, R.P., Kameyama, K., Huganir, R.L., Wolfe, B.B. Standaert, D.G. (2000) Alterations in subunit expression, composition, and phosphorylation of striatal N-methyl-D-aspartate glutamate receptors in a rat 6-hydroxydopamine model of Parkinson's disease. Mol. Pharmacol., 57, 342 352.
31. El Atifi-Borel, M., Buggia-Prevot, V., Platet, N., Benabid, A.L., Berger, F. Sgambato-Faure, V. (2009) De novo and long-term l-Dopa induce both common and distinct striatal gene profiles in the hemiparkinsonian rat. Neurobiol. Dis., 34, 340 350.
32. Galati, S., Mazzone, P., Fedele, E., Pisani, A., Peppe, A., Pierantozzi, M., Brusa, L., Tropepi, D., Moschella, V., Raiteri, M., Stanzione, P., Bernardi, G. Stefani, A. (2006) Biochemical and electrophysiological changes of substantia nigra pars reticulata driven by subthalamic stimulation in patients with Parkinson's disease. Eur. J. Neurosci., 23, 2923 2928.
33. Gardoni, F., Picconi, B., Ghiglieri, V., Polli, F., Bagetta, V., Bernardi, G., Cattabeni, F., Di Luca, M. Calabresi, P. (2006) A critical interaction between NR2B and MAGUK in L-DOPA induced dyskinesia. J. Neurosci., 26, 2914 2922.
34. Grabli, D., McCairn, K., Hirsch, E.C., Agid, Y., Feger, J., Francois, C. Tremblay, L. (2004) Behavioural disorders induced by external globus pallidus dysfunction in primates: I. Behavioural study. Brain, 127, 2039 2054. (Pubitemid 39150262)
35. Gradinaru, V., Mogri, M., Thompson, K.R., Henderson, J.M. Deisseroth, K. (2009) Optical deconstruction of parkinsonian neural circuitry. Science, 324, 354 359.
36. Guridi, J., Herrero, M.T., Luquin, M.R., Guillen, J., Ruberg, M., Laguna, J., Vila, M., Javoy-Agid, F., Agid, Y., Hirsch, E. Obeso, J.A. (1996) Subthalamotomy in parkinsonian monkeys. Behavioural and biochemical analysis. Brain, 119 (Pt 5 1717 1727.
37. Hadj Tahar, A., Gregoire, L., Darre, A., Belanger, N., Meltzer, L. Bedard, P.J. (2004) Effect of a selective glutamate antagonist on L-dopa-induced dyskinesias in drug-naive parkinsonian monkeys. Neurobiol. Dis., 15, 171 176.
38. Hallett, P.J., Dunah, A.W., Ravenscroft, P., Zhou, S., Bezard, E., Crossman, A.R., Brotchie, J.M. Standaert, D.G. (2005) Alterations of striatal NMDA receptor subunits associated with the development of dyskinesia in the MPTP-lesioned primate model of Parkinson's disease. Neuropharmacology, 48, 503 516.
39. Halpern, C.H., Wolf, J.A., Bale, T.L., Stunkard, A.J., Danish, S.F., Grossman, M., Jaggi, J.L., Grady, M.S. Baltuch, G.H. (2008) Deep brain stimulation in the treatment of obesity. J. Neurosurg., 109, 625 634.
40. Hamada, I. DeLong, M.R. (1992) Excitotoxic acid lesions of the primate subthalamic nucleus result in transient dyskinesias of the contralateral limbs. J. Neurophysiol., 68, 1850 1858.
41. Hashimoto, T., Elder, C.M., Okun, M.S., Patrick, S.K. Vitek, J.L. (2003) Stimulation of the subthalamic nucleus changes the firing pattern of pallidal neurons. J. Neurosci., 23, 1916 1923.
42. Hodaie, M., Wennberg, R.A., Dostrovsky, J.O. Lozano, A.M. (2002) Chronic anterior thalamus stimulation for intractable epilepsy. Epilepsia, 43, 603 608.
43. Hurley, M.J., Jackson, M.J., Smith, L.A., Rose, S. Jenner, P. (2005) Immunoautoradiographic analysis of NMDA receptor subunits and associated postsynaptic density proteins in the brain of dyskinetic MPTP-treated common marmosets. Eur. J. Neurosci., 21, 3240 3250.
44. Jenner, P. (2008) Molecular mechanisms of L-DOPA-induced dyskinesia. Nat. Rev. Neurosci., 9, 665 677.
45. Kopp, C., Longordo, F. Luthi, A. (2007) Experience-dependent changes in NMDA receptor composition at mature central synapses. Neuropharmacology, 53, 1 9.
46. Lacombe, E., Khaindrava, V., Melon, C., Oueslati, A., Kerkerian-Le Goff, L. Salin, P. (2009) Different functional basal ganglia subcircuits associated with anti-akinetic and dyskinesiogenic effects of antiparkinsonian therapies. Neurobiol. Dis., 36, 116 125.
47. Lau, C.G. Zukin, R.S. (2007) NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nat. Rev. Neurosci., 8, 413 426.
48. Limousin, P., Pollak, P., Hoffmann, D., Benazzouz, A., Perret, J.E. Benabid, A.L. (1996) Abnormal involuntary movements induced by subthalamic nucleus stimulation in parkinsonian patients. Mov. Disord., 11, 231 235.
49. Liu, Y., Postupna, N., Falkenberg, J. Anderson, M.E. (2008) High frequency deep brain stimulation: what are the therapeutic mechanisms? Neurosci. Biobehav. Rev., 32, 343 351.
50. Matsumura, M., Tremblay, L., Richard, H. Filion, M. (1995) Activity of pallidal neurons in the monkey during dyskinesia induced by injection of bicuculline in the external pallidum. Neuroscience, 65, 59 70.
51. Maurice, N., Thierry, A.M., Glowinski, J. Deniau, J.M. (2003) Spontaneous and evoked activity of substantia nigra pars reticulata neurons during high-frequency stimulation of the subthalamic nucleus. J. Neurosci., 23, 9929 9936.
52. Mayberg, H.S., Lozano, A.M., Voon, V., McNeely, H.E., Seminowicz, D., Hamani, C., Schwalb, J.M. Kennedy, S.H. (2005) Deep brain stimulation for treatment-resistant depression. Neuron, 45, 651 660.
53. McIntyre, C.C., Savasta, M., Kerkerian-Le Goff, L. Vitek, J.L. (2004) Uncovering the mechanism(s) of action of deep brain stimulation: activation, inhibition, or both. Clin. Neurophysiol., 115, 1239 1248.
54. Mela, F., Marti, M., Dekundy, A., Danysz, W., Morari, M. Cenci, M.A. (2007) Antagonism of metabotropic glutamate receptor type 5 attenuates l-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson's disease. J. Neurochem., 101, 483 497.
55. Menegoz, M., Lau, L.F., Hervé, D., Huganir, R.L. Girault, J.A. (1995) Tyrosine phosphorylation of NMDA receptor in rat striatum: effects of 6-OH-dopamine lesions. Neuroreport, 7, 125 128.
56. Menniti, F., Chenard, B., Collins, M., Ducat, M., Shalaby, I. White, F. (1997) CP-101,606, a potent neuroprotectant selective for forebrain neurons. Eur. J. Pharmacol., 331, 117 126.
57. Menniti, F.S., Pagnozzi, M.J., Butler, P., Chenard, B.L., Jaw-Tsai, S.S. Frost White, W. (2000) CP-101,606, an NR2B subunit selective NMDA receptor antagonist, inhibits NMDA and injury induced c-fos expression and cortical spreading depression in rodents. Neuropharmacology, 39, 1147 1155.
58. Morissette, M., Dridi, M., Calon, F., Hadj Tahar, A., Meltzer, L.T., Bedard, P.J. Di Paolo, T. (2006) Prevention of levodopa-induced dyskinesias by a selective NR1A/2B N-methyl-D-aspartate receptor antagonist in parkinsonian monkeys: implication of preproenkephalin. Mov. Disord., 21, 9 17.
59. Moro, E., Esselink, R.J., Benabid, A.L. Pollak, P. (2002) Response to levodopa in parkinsonian patients with bilateral subthalamic nucleus stimulation. Brain, 125, 2408 2417. (Pubitemid 35303501)
60. Nash, J.E., Ravenscroft, P., McGuire, S., Crossman, A.R., Menniti, F.S. Brotchie, J.M. (2004) The NR2B-selective NMDA receptor antagonist CP-101,606 exacerbates L-DOPA-induced dyskinesia and provides mild potentiation of anti-parkinsonian effects of L-DOPA in the MPTP-lesioned marmoset model of Parkinson's disease. Exp. Neurol., 188, 471 479.
61. Nutt, J.G., Gunzler, S.A., Kirchhoff, T., Hogarth, P., Weaver, J.L., Krams, M., Jamerson, B., Menniti, F.S. Landen, J.W. (2008) Effects of a NR2B selective NMDA glutamate antagonist, CP-101,606, on dyskinesia and Parkinsonism. Mov. Disord., 23, 1860 1866.
62. Nuttin, B., Gybels, J., Cosyns, P., Gabriels, L., Meyerson, B., Andreewitch, S., Rasmussen, S.A., Greenberg, B., Friehs, G., Rezai, A.R., Montgomery, E., Malone, D. Fins, J.J. (2003) Deep brain stimulation for psychiatric disorders. Neurosurg. Clin. N. Am., 14, xv xvi.
63. Oh, J.D., Russell, D.S., Vaughan, C.L. Chase, T.N. (1998) Enhanced tyrosine phosphorylation of striatal NMDA receptor subunits: effect of dopaminergic denervation and L-DOPA administration. Brain Res., 813, 150 159.
64. Oh, J.D., Vaughan, C.L. Chase, T.N. (1999) Effect of dopamine denervation and dopamine agonist administration on serine phosphorylation of striatal NMDA receptor subunits. Brain Res., 821, 433 442.
65. Orieux, G., Francois, C., Feger, J. Hirsch, E.C. (2002) Consequences of dopaminergic denervation on the metabolic activity of the cortical neurons projecting to the subthalamic nucleus in the rat. J. Neurosci., 22, 8762 8770.
66. Oueslati, A., Sgambato-Faure, V., Melon, C., Kachidian, P., Gubellini, P., Amri, M., Kerkerian-Le Goff, L. Salin, P. (2007) High-frequency stimulation of the subthalamic nucleus potentiates L-DOPA-induced neurochemical changes in the striatum in a rat model of Parkinson's disease. J. Neurosci., 27, 2377 2386.
67. Peretti-Renucci, R., Feuerstein, C., Manier, M., Lorimier, P., Savasta, M., Thibault, J., Mons, N. Geffard, M. (1991) Quantitative image analysis with densitometry for immunohistochemistry and autoradiography of receptor binding sites - methodological considerations. J. Neurosci. Res., 28, 583 600.
68. Perez-Otano, I. Ehlers, M.D. (2005) Homeostatic plasticity and NMDA receptor trafficking. Trends Neurosci., 28, 229 238.
69. Perier, C., Tremblay, L., Feger, J. Hirsch, E.C. (2002) Behavioral consequences of bicuculline injection in the subthalamic nucleus and the zona incerta in rat. J. Neurosci., 22, 8711 8719.
70. Perlmutter, J.S. Mink, J.W. (2006) Deep brain stimulation. Annu. Rev. Neurosci., 29, 229 257.
71. Picconi, B., Centonze, D., Hakansson, K., Bernardi, G., Greengard, P., Fisone, G., Cenci, M.A. Calabresi, P. (2003) Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia. Nat. Neurosci., 6, 501 506.
72. Pollak, P., Benabid, A.L., Gross, C., Gao, D.M., Laurent, A., Benazzouz, A., Hoffmann, D., Gentil, M. Perret, J. (1993) [Effects of the stimulation of the subthalamic nucleus in Parkinson disease]. Rev. Neurol. (Paris), 149, 175 176.
73. Qiang, M. Ticku, M.K. (2005) Role of AP-1 in ethanol-induced N-methyl-D-aspartate receptor 2B subunit gene up-regulation in mouse cortical neurons. J. Neurochem., 95, 1332 1341.
74. Robelet, S., Melon, C., Guillet, B., Salin, P. Kerkerian-Le Goff, L. (2004) Chronic L-DOPA treatment increases extracellular glutamate levels and GLT1 expression in the basal ganglia in a rat model of Parkinson's disease. Eur. J. Neurosci., 20, 1255 1266.
75. Rylander, D., Recchia, A., Mela, F., Dekundy, A., Danysz, W. Cenci, M.A. (2009) Pharmacological modulation of glutamate transmission in a rat model of L-DOPA-induced dyskinesia: effects on motor behavior and striatal nuclear signaling. J. Pharmacol. Exp. Ther., 330, 227 335.
76. Salin, P., Manrique, C., Forni, C. Kerkerian-Le Goff, L. (2002) High-frequency stimulation of the subthalamic nucleus selectively reverses dopamine denervation-induced cellular defects in the output structures of the basal ganglia in the rat. J. Neurosci., 22, 5137 5148.
77. Schulte, T., Brecht, S., Herdegen, T., Illert, M., Mehdorn, H.M. Hamel, W. (2006) Induction of immediate early gene expression by high-frequency stimulation of the subthalamic nucleus in rats. Neuroscience, 138, 1377 1385.
78. Schuurman, P.R., Bosch, D.A., Bossuyt, P.M., Bonsel, G.J., van Someren, E.J., de Bie, R.M., Merkus, M.P. Speelman, J.D. (2000) A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor. N. Engl. J. Med., 342, 461 468.
79. Sgambato, V., Vanhoutte, P., Pages, C., Rogard, M., Hipskind, R., Besson, M.J. Caboche, J. (1998) In vivo expression and regulation of Elk-1, a target of the extracellular-regulated kinase signaling pathway, in the adult rat brain. J. Neurosci., 18, 214 226.
80. Sgambato-Faure, V., Buggia, V., Gilbert, F., Levesque, D., Benabid, A.L. Berger, F. (2005) Coordinated and spatial upregulation of arc in striatonigral neurons correlates with L-dopa-induced behavioral sensitization in dyskinetic rats. J. Neuropathol. Exp. Neurol., 64, 936 947.
81. Snyder, E.M., Nong, Y., Almeida, C.G., Paul, S., Moran, T., Choi, E.Y., Nairn, A.C., Salter, M.W., Lombroso, P.J., Gouras, G.K. Greengard, P. (2005) Regulation of NMDA receptor trafficking by amyloid-beta. Nat. Neurosci., 8, 1051 1058.
82. Standaert, D.G., Friberg, I.K., Landwehrmeyer, G.B., Young, A.B. Penney, J.B. Jr. (1999) Expression of NMDA glutamate receptor subunit mRNAs in neurochemically identified projection and interneurons in the striatum of the rat. Brain Res. Mol. Brain Res., 64, 11 23.
83. Vidailhet, M., Vercueil, L., Houeto, J.L., Krystkowiak, P., Benabid, A.L., Cornu, P., Lagrange, C., Tezenas du Montcel, S., Dormont, D., Grand, S., Blond, S., Detante, O., Pillon, B., Ardouin, C., Agid, Y., Destee, A. Pollak, P. (2005) Bilateral deep-brain stimulation of the globus pallidus in primary generalized dystonia. N. Engl. J. Med., 352, 459 467. (Pubitemid 40175972)
84. Welter, M.L., Houeto, J.L., Bonnet, A.M., Bejjani, P.B., Mesnage, V., Dormont, D., Navarro, S., Cornu, P., Agid, Y. Pidoux, B. (2004) Effects of high-frequency stimulation on subthalamic neuronal activity in parkinsonian patients. Arch. Neurol., 61, 89 96.
85. Wessell, R.H., Ahmed, S.M., Menniti, F.S., Dunbar, G.L., Chase, T.N. Oh, J.D. (2004) NR2B selective NMDA receptor antagonist CP-101,606 prevents levodopa-induced motor response alterations in hemi-parkinsonian rats. Neuropharmacology, 47, 184 194.
86. Windels, F., Bruet, N., Poupard, A., Urbain, N., Chouvet, G., Feuerstein, C. Savasta, M. (2000) Effects of high frequency stimulation of subthalamic nucleus on extracellular glutamate and GABA in substantia nigra and globus pallidus in the normal rat. Eur. J. Neurosci., 12, 4141 4146.
87. Windels, F., Bruet, N., Poupard, A., Feuerstein, C., Bertrand, A. Savasta, M. (2003) Influence of the frequency parameter on extracellular glutamate and gamma-aminobutyric acid in substantia nigra and globus pallidus during electrical stimulation of subthalamic nucleus in rats. J. Neurosci. Res., 72, 259 267.
88. Windels, F., Carcenac, C., Poupard, A. Savasta, M. (2005) Pallidal origin of GABA release within the substantia nigra pars reticulata during high-frequency stimulation of the subthalamic nucleus. J. Neurosci., 25, 5079 5086.